Incannex Healthcare (ASX: IHL) using medicinal cannabis to treat illnesses with unmet needs (w/ Dr Sud Agarwal)

Small Caps - A podcast by Small Caps

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Business

Incannex Healthcare (ASX: IHL) chief medical officer Dr Sud Agarwal joins Small Caps to discuss the company's clinical trials involving medicinal cannabis to treat a number of ailments including: obstructive sleep apnoea (OSA), sepsis associated acute respiratory distress syndrome (SAARDS) and traumatic brain injury (TBI).